{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.00","upperLimit":"123.00","value":"32.50"},{"groupId":"OG001","lowerLimit":"0.00","upperLimit":"141.00","value":"43.50"},{"groupId":"OG002","lowerLimit":"1.00","upperLimit":"122.00","value":"42.00"},{"groupId":"OG003","lowerLimit":"1.00","upperLimit":"206.00","value":"60.50"},{"groupId":"OG004","lowerLimit":"3.00","upperLimit":"119.00","value":"35.50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"12"}],"units":"Participants"}],"title":"Day 5 (1st leukapheresis session)"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.00","upperLimit":"59.50","value":"16.00"},{"groupId":"OG001","lowerLimit":"14.00","upperLimit":"45.00","value":"28.00"},{"groupId":"OG002","lowerLimit":"0.00","upperLimit":"45.00","value":"20.00"},{"groupId":"OG003","lowerLimit":"2.00","upperLimit":"70.00","value":"34.00"},{"groupId":"OG004","lowerLimit":"16.00","upperLimit":"45.00","value":"21.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"6"}],"units":"Participants"}],"title":"Day 6 (2nd leukapheresis session)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"12"}],"units":"Participants"}],"description":"determine circulating CD34+ cell counts in peripheral blood","dispersionType":"Full Range","groups":[{"description":"Circulating CD34+ Cell Count (cells/µL) in Peripheral Blood at Pre-dose timepoint","id":"OG000","title":"Pre-dose"},{"description":"Circulating CD34+ Cell Count (cells/µL) in Peripheral Blood at 4h post-infusion timepoint","id":"OG001","title":"4h Post-infusion"},{"description":"Circulating CD34+ Cell Count (cells/µL) in Peripheral Blood at 6h post-infusion timepoint","id":"OG002","title":"6h Post-infusion"},{"description":"Circulating CD34+ Cell Count (cells/µL) in Peripheral Blood at Pre-leukapheresis timepoint","id":"OG003","title":"Pre-leukapheresis"},{"description":"Circulating CD34+ Cell Count (cells/µL) in Peripheral Blood at Post-leukapheresis timepoint","id":"OG004","title":"Post-leukapheresis"}],"paramType":"MEDIAN","populationDescription":"There were 5 patients who achived target number of CD34+ cells (\\>=5.0\\*10\\^6 cells/kg) within two leukapheresis sessions and therefore didn't undergo addtional sessions. Among 7 patients who undergone 6 sessions, there were 1 patient didn't collect blood sample at 4h, 6h post-infusion and post-leukapheresis, and 1 patient 6h post-infusion not done.","reportingStatus":"POSTED","timeFrame":"Day 5 (1st leukapheresis session) to Day 6 (2nd leukapheresis session)","title":"the Pharmacodynamics (PD) Following Treatment With TG-0054 When Combined With G-CSF","type":"SECONDARY","unitOfMeasure":"cells/µL"}